ZA901747B - Use of inhaled loop diuretics for treating allergen-induced nasal reactions - Google Patents

Use of inhaled loop diuretics for treating allergen-induced nasal reactions

Info

Publication number
ZA901747B
ZA901747B ZA901747A ZA901747A ZA901747B ZA 901747 B ZA901747 B ZA 901747B ZA 901747 A ZA901747 A ZA 901747A ZA 901747 A ZA901747 A ZA 901747A ZA 901747 B ZA901747 B ZA 901747B
Authority
ZA
South Africa
Prior art keywords
loop diuretics
induced nasal
allergen
reactions
nasal reactions
Prior art date
Application number
ZA901747A
Other languages
English (en)
Inventor
Sebastiano-Bianco
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA901747B publication Critical patent/ZA901747B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Steroid Compounds (AREA)
ZA901747A 1989-03-08 1990-03-07 Use of inhaled loop diuretics for treating allergen-induced nasal reactions ZA901747B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3907414A DE3907414A1 (de) 1989-03-08 1989-03-08 Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen

Publications (1)

Publication Number Publication Date
ZA901747B true ZA901747B (en) 1990-11-28

Family

ID=6375791

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901747A ZA901747B (en) 1989-03-08 1990-03-07 Use of inhaled loop diuretics for treating allergen-induced nasal reactions

Country Status (18)

Country Link
US (1) US5392767A (da)
EP (1) EP0386700B1 (da)
JP (1) JPH02279625A (da)
KR (1) KR900013955A (da)
CN (1) CN1045350A (da)
AT (1) ATE82853T1 (da)
AU (1) AU623502B2 (da)
CA (1) CA2011680A1 (da)
DD (1) DD292380A5 (da)
DE (2) DE3907414A1 (da)
DK (1) DK0386700T3 (da)
ES (1) ES2052998T3 (da)
GR (1) GR3007175T3 (da)
HU (1) HU205852B (da)
IE (1) IE900811L (da)
IL (1) IL93663A (da)
NO (1) NO901078L (da)
ZA (1) ZA901747B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
DE4023086A1 (de) * 1990-07-20 1992-01-23 Hoechst Ag Methode zur behandlung von allergischer konjunktivitis
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
ES2293875T3 (es) 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
JP4795637B2 (ja) 2001-09-28 2011-10-19 カーブ テクノロジー，インコーポレイティド 鼻ネブライザー
US8168674B1 (en) 2002-02-22 2012-05-01 Microdose Therapeutx, Inc. Method for treating bronchial diseases
WO2003099359A1 (en) 2002-05-09 2003-12-04 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
US8001963B2 (en) * 2003-09-05 2011-08-23 Kurve Technology, Inc. Integrated nebulizer and particle dispersion chamber for nasal delivery of medicament to deep nasal cavity and paranasal sinuses
WO2005023334A2 (en) * 2003-09-05 2005-03-17 Kurve Technology, Inc. Nasal adapter for the base of the nose
CA2698137A1 (en) * 2006-08-30 2008-03-06 Kurve Technology, Inc. Aerosol generating and delivery device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3500M (fr) * 1964-06-15 1965-08-23 Fo We Forschungs Und Verwertun Nouveau médicament destiné au traitement des rhinites.
NZ209900A (en) * 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤

Also Published As

Publication number Publication date
EP0386700A1 (de) 1990-09-12
NO901078L (no) 1990-09-10
DE59000518D1 (de) 1993-01-14
HU205852B (en) 1992-07-28
KR900013955A (ko) 1990-10-22
IL93663A (en) 1994-11-11
IL93663A0 (en) 1990-12-23
AU5075090A (en) 1990-10-11
HU901321D0 (en) 1990-05-28
CA2011680A1 (en) 1990-09-08
DK0386700T3 (da) 1993-03-01
CN1045350A (zh) 1990-09-19
IE900811L (en) 1990-09-08
GR3007175T3 (da) 1993-07-30
HUT52953A (en) 1990-09-28
ES2052998T3 (es) 1994-07-16
DD292380A5 (de) 1991-08-01
EP0386700B1 (de) 1992-12-02
ATE82853T1 (de) 1992-12-15
DE3907414A1 (de) 1990-09-13
US5392767A (en) 1995-02-28
NO901078D0 (no) 1990-03-07
JPH02279625A (ja) 1990-11-15
AU623502B2 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
IE900811L (en) Use of inhaled loop diuretics for treating allergen-induced¹nasal reactions
ATE132747T1 (de) Sprays zur behandlung von infektionen des tractus respiratorius
CY2123B1 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
FI962493A (fi) Alfa-2-adrenoseptoriagonisteina käyttökelpoisia 6-(2-imidatsolinyyliamino)kinoksaliiniyhdisteitä
GB8916625D0 (en) Respiratory tract spray preparations
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
SG86284A1 (en) Use of (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide for the manufacture of medicaments for the treatment of anxiety
PL315058A1 (en) 7-(2-imidazolynyl amino) quinolinic compounds useful as antagonists of a- 2-adrenoreceptors
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
ITMI922778A1 (it) Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii: c-fvw) da plasma umano totale.
IL86077A0 (en) Receptor of the small rhinovirus receptor group,its preparation and pharmaceutical compositions containing it
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
ZA885335B (en) Leukotriene antagonists,processes for the preparation thereof,the use thereof for the treatment of diseases,and precursors
FR2694500B1 (fr) Nébuliseur polyvalent pour le traitement des voies respiratoires.
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
IT9041667A0 (it) Inalatore per aerosolterapia basato sul sistema "usa e getta" dei due componenti "mascherina per inalazione" e "contenitore portafarmaco".
IT9030691V0 (it) Inalatore per aerosolterapia basato sul sistema "usa e getta" dei due componenti "mascheria per inalazione " e "contenitore portafarmaco"